Frontlight ResearchEarly access
Trial site
Wojewodzki Szpital Specjalistyczny w Legnicy
- 10running trials
- 8closed trials
The trials here
What the 18 trials at this site are about, from their registry records.
- Conditions
- Chronic lymphocytic leukaemia7 trials
- Multiple myeloma4 trials
- Diffuse large B-cell lymphoma2 trials
- Myelodysplastic syndromes2 trials
- Acute lymphoblastic leukaemia1 trial
- Acute myeloid leukaemia1 trial
- Childhood cancers1 trial
- Chronic myeloid leukaemia1 trial
- Coronary artery disease1 trial
- Heart failure1 trial
- Hodgkin lymphoma1 trial
- Phase
- Phase 314 trials
- Phase 23 trials
- Phase 41 trial
- Status
- Completed8 trials
- Recruiting7 trials
- Active, not recruiting3 trials
- Lead sponsor
- Janssen Research & Development, LLC3 trials
- Ascentage Pharma Group Inc.2 trials
- BeiGene2 trials
- Dizal Pharmaceuticals1 trial
- Grifols Therapeutics LLC1 trial
- and 9 more
Running trials
Recruiting
A Study of DZD8586 Versus Investigator's Choice in r/r CLL/SLL (TAI-SHAN6)
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic lymphocytic leukaemia3 recruiting
- Chronic myeloid leukaemia1 recruiting
- Coronary artery disease1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Heart failure1 recruiting
- Hodgkin lymphoma1 recruiting
- Multiple myeloma1 recruiting
- Myelodysplastic syndromes1 recruiting
Closed trials
Active, not recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Active, not recruiting
Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Site data: ClinicalTrials.govUpdated 12 Nov 2026